Integral Health Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$3.64M	Buy	+100,000	New	+$3.64M	0.33%	60
2021 Q2	–	Sell	-10,000	Closed	-$1.14M	–	87
2021 Q1	$1.14M	Buy	+10,000	New	+$1.14M	0.33%	61